Sol-Gel Adds $9 Million

Sol-Gel Ltd., a Revohot, Israel-based developer of topical products for the dermatology market, has raised $9 million in new VC funding. Medica Venture Partners led the round, and was joined by return backers JVP and DSM Corporate Venturing. The company had previously raised around $16.5 million since 2003.

18 November 2008•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail